This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Limited Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer, Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer or Tobacco Use Disorder
and you are
over 18
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This randomized clinical trial studies enhanced quitline intervention in smoking cessation for patients with non-metastatic lung cancer. Stop-smoking plans suggested by doctors may help patients with early-stage cancer quit smoking

Provided treatments

  • Other: questionnaire administration
  • Procedure: quality-of-life assessment
  • Other: counseling intervention
  • Other: internet-based intervention
  • Behavioral: telephone-based intervention
  • Other: educational intervention
  • Drug: nicotine replacement therapy
  • Other: educational intervention

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01457469. The sponsor of the trial is Wake Forest University Health Sciences and it is looking for 6 volunteers for the current phase.
Official trial title:
Adapting Smoking Cessation Interventions for the Outpatient Oncology Setting